Online health brand Ro has been expanding beyond the pharmacy with at-home blood draws and vaccine delivery. Now it’s moving into fertility care with the acquisition of personal testing company Modern Fertility. The purchase shows that Ro sees women’s health as a key area of development. But it also represents the ways in which the company plans to push the boundaries of virtual and at-home healthcare through testing and health tracking.
The deal—Ro’s biggest acquisition to date—is said to be valued at more than $225 million, according to a person with knowledge of the arrangement. Founded in 2017, Modern Fertility is a pioneer of the so-called fem-tech market. In 2018, the company began shipping at-home blood tests that analyzed hormone levels to understand aspects of a person’s fertility. The test costs $159 and includes a consultation with a nurse. The company has since launched a pregnancy test, prenatal vitamin, ovulation test strips, an app for fertility tracking,…
Read More…
Source : fastcompany.com
Source link
